Advertisement
U.S. markets open in 2 hours 28 minutes

Fresenius Medical Care AG (FMS)

NYSE - NYSE Delayed Price. Currency in USD
19.03-0.01 (-0.05%)
At close: 04:00PM EDT
19.18 +0.15 (+0.79%)
Pre-Market: 06:38AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Down

Gap Down

Previous Close19.04
Open19.08
Bid19.18 x 1400
Ask19.20 x 1100
Day's Range18.92 - 19.11
52 Week Range16.37 - 27.72
Volume396,466
Avg. Volume446,476
Market Cap11.167B
Beta (5Y Monthly)0.94
PE Ratio (TTM)20.46
EPS (TTM)0.93
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 13, 2022
1y Target Est19.26
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
49% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for FMS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Fresenius Medical Care AG
    Analyst Report: Fresenius Medical Care AGFresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
    Rating
    Fair Value
    Economic Moat
    14 days agoMorningstar
View more